E-LIB Suche - Ergebnisse für: Prabhu, Kevin

1

Perioperative Outcomes, Comorbidities, and Complications fo..:

Prabhu, Kevin ; Nasr, Andrew J. ; Kasitinon, Donald..
Journal of Clinical Medicine. 12 (2023) 18 - p. 5799 , 2023

Link: https://doi.org/10.3390/..

2

Perioperative Outcomes, Comorbidities, and Complications fo..:

Prabhu, Kevin ; Nasr, Andrew J ; Kasitinon, Donald..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532280/. , 2023

Link: http://www.ncbi.nlm.nih...

3

Perioperative Outcomes, Comorbidities, and Complications fo..:

Kevin Prabhu ; Andrew J. Nasr ; Donald Kasitinon..
Clinical Rehabilitation. , 2023

Link: https://doi.org/10.3390/..

4

Perioperative Outcomes, Comorbidities, and Complications fo..:

Kevin Prabhu ; Andrew J. Nasr ; Donald Kasitinon..
https://www.mdpi.com/2077-0383/12/18/5799. , 2023

Link: https://doi.org/10.3390/..

5

Risk Factors for Hematotoxicity Following Tisagenlecleucel ..:

McNerney, Kevin Owen ; Fabrizio, Vanessa A. ; Talleur, Aimee C....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S219-S220 , 2024

Link: https://doi.org/10.1016/..

6

High Disease Burden and Severe Neutropenia Predict HLH Toxi..:

McNerney, Kevin O. ; Lim, Stephanie Si ; Miller, Alexandra...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S202-S203 , 2023

Link: https://doi.org/10.1016/..

7

CSIG-33. A 2ND GENERATION IDO1 PROTEIN DEGRADER TO OVERCOME..:

Bommi, Prashant ; Monsen, Paige ; Lauing, Kristen...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v47-v47 , 2023

Link: https://doi.org/10.1093/..

8

List of contributors:

, In: QSAR in Safety Evaluation and Risk Assessment,

Akortia, Eric ; Alla, Sai Radha Mani ; Alves, Vinicius M.... - p. xv-xviii , 2023

Link: https://doi.org/10.1016/..

9

IMMU-27. NON-TUMOR CELL IDO1 NON-ENZYMATICALLY DECREASES RT..:

Zhai, Lijie ; Bell, April ; Asimakidou, Evridiki...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v147-v148 , 2023

Link: https://doi.org/10.1093/..

10

HLH-like toxicities predict poor survival after the use of ..:

McNerney, Kevin O. ; Si Lim, Stephanie J. ; Ishikawa, Kyle...
Blood Advances. 7 (2023) 12 - p. 2758-2771 , 2023

Link: https://doi.org/10.1182/..

11

CNSC-20. MGMT PROMOTER METHYLATED HIGH GRADE GLIOMA WITH DI..:

Jani, Ronak ; Lee, Jonathan ; Jusue-Torres, Ignacio...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v26-v27 , 2023

Link: https://doi.org/10.1093/..

12

Mediport Use As an Acceptable Standard for CAR T Cell Infus..:

Eylon, Maya ; Baggott, Christina ; Prabhu, Snehit...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S195-S196 , 2023

Link: https://doi.org/10.1016/..

13

PATH-04. TRANSFORMATION OF GRADE 2 OLIGODENDROGLIOMA TO GLI..:

Jani, Ronak ; Casinelli, Eric ; Goyal, Abhishek...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v167-v167 , 2023

Link: https://doi.org/10.1093/..

14

EXTH-41. COMBINATION TREATMENT OF CALCIUM CHANNEL ANTAGONIS..:

White, Erik ; Prabhu, Michael ; Thakkar, Jigisha...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v233-v233 , 2023

Link: https://doi.org/10.1093/..

15

Tisagenlecleucel utilisation and outcomes across refractory..:

Barsan, Valentin ; Li, Yimei ; Prabhu, Snehit...
eClinicalMedicine. 65 (2023) - p. 102268 , 2023

Link: https://doi.org/10.1016/..